Pharma Industry Needs Precise FDA Guidelines for AI, ML, and RPA Validation : Experts

​Experts at the second edition of Next-Gen LabCon discussed the capabilities of artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA) in enhancing research and development (R&D) processes. The panel experts underscored the transformative potential of AI, ML, and RPA in pharmaceutical R&D while highlighting the critical need for human expertise and robust regulatory frameworks.
Source – ETHealth World